午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频
TargetMol Chemicals Inc. Company Information
Company Name:
TargetMol Chemicals Inc.
Tel:
-
Email:
marketing@targetmol.com
Nationality:
United States
WebSite:
www.targetmol.com/
Product List:
32368
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
Product List
Nonivamide
2444-46-4
Trombodipine
113658-85-8
PF-06733804
1873373-33-1
TRPC6-IN-1
901715-05-7
UPF-648 sodium salt
1465017-87-1
(S)-Rasagiline;TVP1022;S-PAI
185517-74-2
Trimetazidine-N-oxide
1644530-89-1
Tris(2,4-di-tert-butylphenyl)phosphate
95906-11-9
Tropodifene;Tropaphen
15790-02-0
O-Phospho-L-serine
407-41-0
T 82
252264-92-9
Ubiquinol;CoQH2-10;Ubiquinol-10
992-78-9
UCSF924
1434515-70-4
UK51656
88150-59-8
Trovafloxacin
147059-72-1
TTA-Q6
910484-28-5
Upamostat
590368-25-5
Trovafloxacin mesylate
147059-75-4
Bendazol
621-72-7
TrkA-IN-1
1680179-43-4
Tromantadine hydrochloride
41544-24-5
TSHR antagonist S37
1217616-61-9
N-(3-Chloro-4-morpholinophenyl)-N'-hydroxyformimidamide;TS-011
339071-18-0
TRPA1 Antagonist 1
1984825-08-2
TSHR antagonist S37a
2143452-20-2
TTP-8307
950225-08-8
Tubulin inhibitor 7
1309925-41-4
Tromantadine
53783-83-8
Tubulysin D
309935-57-7
Oliceridine hydrochloride;TRV130 (hydrochloride)
1401031-39-7
TyK2-IN-2
2098466-94-3
UNC10217938A
1347749-97-6
Ubiquitination-IN-1
1819330-15-8
UK-101
1000313-40-5
Tyk2-IN-9
2127109-85-5
Oliceridine (Racemate);TRV130 (Racemate)
1401028-25-8
TT-OAD2
2382719-60-8
Tubulin inhibitor 6
105925-39-1
Artemether
71963-77-4
Tubulin inhibitor 1
2237054-53-2
trans-Doxercalciferol
74007-20-8
Triamcinolone Benetonide
31002-79-6
Disopyramide
3737-09-5
Triacsin C;FR 900190;WS 1228A
76896-80-5
Trilaciclib hydrochloride
1977495-97-8
UKI-1;UKI-1C
220355-63-5
Umibecestat
1387560-01-1
UK-370106
230961-21-4
UbcH5c-IN-1
2123480-72-6
Tubulin inhibitor 8
1309925-39-0
Tunicamycin
11089-65-9
(S)-Rasagiline mesylate;TVP1022 (mesylate);S-PAI mesylate
202464-88-8
Tyk2-IN-5
1797432-62-2
Tyk2-IN-7
1609391-90-3
UCT943
1450666-80-4
Carprofen
53716-49-7
Uridine 5'-diphosphate sodium salt
21931-53-3
COX/5-LO-IN-1;Atreleuton analog
154355-75-6
EHP-101
1818428-24-8
URAT1 inhibitor 1
2268720-62-1
Valsartan Ethyl Ester
1111177-30-0
Usaramine N-oxide
117020-54-9
VAF347
574759-62-9
DL-trihexyphenidyl hydrochloride
58947-95-8
Vabicaserin hydrochloride
887258-94-8
VBY-825
1310340-58-9
USP7-IN-1
1381291-36-6
Valemetostat tosylate;DS-3201 tosylate
1809336-93-3
USP7-IN-3
2202738-42-7
USP7-IN-5
2166599-74-0
USP7-IN-6
2166586-47-4
UT-155
2031161-35-8
Nortriptyline hydrochloride
894-71-3
CCK-B Receptor Antagonist 1
168161-71-5
Gentamicin sulfate
1405-41-0
Valecobulin hydrochloride
1240321-53-2
Gastrin/CCK antagonist 1
162271-52-5
Urolithin B
1139-83-9
Vatinoxan hydrochloride;MK-467 hydrochloride;L-659066 hydrochloride
130466-38-5
UT-34
2168525-92-4
Valsartan-d9;CGP-48933 D9;Valsartan D9
1089736-73-1
USP30 inhibitor 11
2067332-64-1
U91356
152886-85-6
Triphala
857906-76-4
Valerylcarnitine
40225-14-7
Valategrast;R-411 free base
220847-86-9
TXNIP-IN-1
1268955-50-5
TTT-28
1609138-51-3
Tuberculosis inhibitor 1
2230810-28-1
TTA-Q6(isomer)
910484-32-1
UK-240455
178908-09-3
TRPV4 agonist-1
2314467-60-0
Valopicitabine;NM283
640281-90-9
Utibapril;FPL 63547
109683-61-6
Tyk2-IN-3
1779493-12-7
VBIT-4
2086257-77-2
Vapendavir diphosphate;BTA798 diphosphate
1198151-75-5
FCE 28654
169474-77-5
Tyrphostin AG1433
168835-90-3
UP202-56
163838-04-8
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
Copyright 2007© ChemicalBook. All rights reserved.